Short Interest in Concord Medical Services Holdings Limited (NYSE:CCM) Drops By 60.1%

Concord Medical Services Holdings Limited (NYSE:CCM) saw a large decline in short interest in the month of July. As of July 15th, there was short interest totaling 2,980 shares, a decline of 60.1% from the June 30th total of 7,461 shares. Based on an average trading volume of 77,063 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.1% of the shares of the company are short sold.

Concord Medical Services Stock Up 2.2%

Shares of Concord Medical Services stock traded up $0.10 during trading on Tuesday, hitting $4.61. The stock had a trading volume of 32,973 shares, compared to its average volume of 63,917. Concord Medical Services has a 1 year low of $3.18 and a 1 year high of $6.98. The stock has a 50 day simple moving average of $4.67 and a 200 day simple moving average of $4.27. The company has a debt-to-equity ratio of 1.33, a quick ratio of 0.46 and a current ratio of 0.48.

Concord Medical Services (NYSE:CCM) last issued its earnings results on Wednesday, April 29th. The company reported ($1.08) EPS for the quarter.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Concord Medical Services in a research note on Tuesday, May 26th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Concord Medical Services has a consensus rating of “Sell”.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.